Endotoxin, sepsis, and the primrose path

被引：70

作者：

O'Reilly, M

Newcomb, DE

Remick, D

机构：

[1] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA

[2] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA

来源：

SHOCK | 1999年 / 12卷 / 06期

关键词：

D O I：

10.1097/00024382-199912000-00001

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

[No abstract available]

引用

页码：411 / 420

页数：10

共 135 条

[1] EFFICACY AND SAFETY OF MONOCLONAL-ANTIBODY TO HUMAN TUMOR-NECROSIS-FACTOR-ALPHA IN PATIENTS WITH SEPSIS SYNDROME - A RANDOMIZED, CONTROLLED, DOUBLE-BLIND, MULTICENTER CLINICAL-TRIAL [J].

ABRAHAM, E ;

WUNDERINK, R ;

SILVERMAN, H ;

PERL, TM ;

NASRAWAY, S ;

LEVY, H ;

BONE, R ;

WENZEL, RP ;

BALK, R ;

ALLRED, R ;

PENNINGTON, JE ;

WHERRY, JC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (12) :934-941

[2] p55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock - A randomized controlled multicenter trial [J].

Abraham, E ;

Glauser, MP ;

Butler, T ;

Garbino, J ;

Gelmont, D ;

Laterre, PF ;

Kudsk, K ;

Bruining, HA ;

Otto, C ;

Tobin, E ;

Zwingelstein, C ;

Lesslauer, W ;

Leighton, A .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (19) :1531-1538

[3] INTERLEUKIN-1 (IL-1) RECEPTOR ANTAGONIST PREVENTS STAPHYLOCOCCUS-EPIDERMIDIS-INDUCED HYPOTENSION AND REDUCES CIRCULATING LEVELS OF TUMOR-NECROSIS-FACTOR AND IL-1-BETA IN RABBITS [J].

AIURA, K ;

GELFAND, JA ;

BURKE, JF ;

THOMPSON, RC ;

DINARELLO, CA .

INFECTION AND IMMUNITY, 1993, 61 (08) :3342-3350

[4] A RECOMBINANT HUMAN RECEPTOR ANTAGONIST TO INTERLEUKIN-1 IMPROVES SURVIVAL AFTER LETHAL ENDOTOXEMIA IN MICE [J].

ALEXANDER, HR ;

DOHERTY, GM ;

BURESH, CM ;

VENZON, DJ ;

NORTON, JA .

JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (04) :1029-1032

[5]

ALEXANDER HR, 1991, J SURG RES, V50, P421

[6] PROTECTION AGAINST ENDOTOXIC-SHOCK BY A TUMOR-NECROSIS-FACTOR RECEPTOR IMMUNOADHESIN [J].

ASHKENAZI, A ;

MARSTERS, SA ;

CAPON, DJ ;

CHAMOW, SM ;

FIGARI, IS ;

PENNICA, D ;

GOEDDEL, DV ;

PALLADINO, MA ;

SMITH, DH .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (23) :10535-10539

[7] DIVERGENT EFFICACY OF ANTIBODY TO TUMOR-NECROSIS-FACTOR-ALPHA IN INTRAVASCULAR AND PERITONITIS MODELS OF SEPSIS [J].

BAGBY, GJ ;

PLESSALA, KJ ;

WILSON, LA ;

THOMPSON, JJ ;

NELSON, S .

JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (01) :83-88

[8]

Bengtsson A, 1998, SCAND J IMMUNOL, V48, P509

[9] PASSIVE-IMMUNIZATION AGAINST CACHECTIN TUMOR NECROSIS FACTOR PROTECTS MICE FROM LETHAL EFFECT OF ENDOTOXIN [J].

BEUTLER, B ;

MILSARK, IW ;

CERAMI, AC .

SCIENCE, 1985, 229 (4716) :869-871

[10] PROTECTIVE EFFECTS OF TUMOR NECROSIS FACTOR IN EXPERIMENTAL LEGIONELLA-PNEUMOPHILA INFECTIONS OF MICE VIA ACTIVATION OF PMN FUNCTION [J].

BLANCHARD, DK ;

DJEU, JY ;

KLEIN, TW ;

FRIEDMAN, H ;

STEWART, WE .

JOURNAL OF LEUKOCYTE BIOLOGY, 1988, 43 (05) :429-435

← 1 2 3 4 5 6 7 8 9 10 →